Cargando…
Endothelial Dysfunction in Breast Cancer Survivors on Aromatase Inhibitors: Changes over Time
BACKGROUND: Aromatase inhibitors (AIs) are recommended as adjuvant treatment for estrogen-receptor positive breast carcinoma in postmenopausal women. Studies demonstrate mixed results as to the impact of AIs on cardiovascular (CV) events and overall survival. With the increasing number of pre- and p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104271/ https://www.ncbi.nlm.nih.gov/pubmed/37066265 http://dx.doi.org/10.21203/rs.3.rs-2758909/v1 |